Redeye remains positive towards Avensia despite a soft Q4 report and reduced forecasts. Several factors hurt margins in the quarter, coming in below our forecasts – although still improving y/y. Nevertheless, we believe Avensia is set for further improvements in profitability gradually throughout 2024.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases